Delivery Order SPE2DB22D3301-SPE2DB24FY1NU
Award Date
2/28/24
Potential Completion Date
2/29/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,325.23 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets, with a completion date of February 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,468.64 and is a Firm Fixed Price Delivery Order that runs through February 28, 2024. The contract was awarded on February 27, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,698.91 for the provision of 4,562,939,577 units of Bupropion HCL XL 300 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 30, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4563636625 - Bupropion HCL XL 150 mg tablets. The $10,420.09 firm-fixed-price contract has a completion date of February 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, valued at $13,869.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets in quantities of 500 tablets per bottle. This is a Firm Fixed Price Delivery Order contract with a completion date of February 8, 2024. The contract was awarded on February 7, 2024 and does not have a set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $57,461.12 for the supply of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022 through full and open competition, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This contract award, valued at $29,606.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,323,524 units of Bupropion HCL XL 300 mg tablets, with a completion date of January 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $43,909.44 delivery order contract is for the supply of Bupropion HCL XL 150 mg tablets, with a completion date of December 11, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $53,758.07 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets to support military and veterans' healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $34,961.14, is for the delivery of Bupropion HCL XL 300 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract was awarded on February 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...